Torrent Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Court Convened General Meeting held on April 28, 2026
TORNTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Torrent Pharmaceuticals Limited held its NCLT-convened Equity Shareholders meeting on April 28, 2026 to approve the Scheme of Amalgamation of J.B. Chemicals & Pharmaceuticals Limited (JB Pharma) with the Company. The resolution was passed with an overwhelming majority — 100% of valid votes (31,49,96,459 votes worth ₹1,574.98 crore) were cast in favour out of 31,49,96,800 valid votes. Only 8 public shareholders (0.67%) voted against, representing just 341 votes. Promoters (9 shareholders holding 23,11,85,400 shares) voted unanimously in favour. The meeting was held via video conferencing with a quorum present throughout. The scrutinizer confirmed the resolution was passed as required under Section 230(6) of the Companies Act, 2013.
Shareholders of Torrent Pharmaceuticals have approved the key step in acquiring JB Pharma. The scheme still requires NCLT approval and other regulatory clearances before completion. This acquisition will expand Torrent Pharma's product portfolio and market presence in the domestic pharmaceutical space.